Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy
- PMID: 20041244
- DOI: 10.1007/s00268-009-0356-0
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy
Abstract
Background: The extent of surgery for papillary carcinoma significantly differs between western countries and Japan. Almost routine total thyroidectomy with radioiodine ablation therapy has been performed in western countries, whereas limited thyroidectomy has been adopted in Japan, especially for low-risk cases. In this study, the prognosis of patients with solitary papillary carcinoma measuring 2 cm or less without massive extrathyroid extension, clinically apparent lymph node metastasis or distant metastasis at diagnosis (T1N0M0 in the UICC TNM classification) was investigated to elucidate the appropriate extent of surgery for these patients.
Methods: We investigated the prognosis of 2,638 patients with solitary T1N0M0 papillary carcinoma who underwent initial surgery between 1987 and 2004. Total or near total thyroidectomy was performed for 1,037 patients and the remaining 1,601 patients underwent more limited thyroidectomy. Elective central node dissection was performed for 2,511 patients, accounting for 96%, and 1,545 (59%) also underwent prophylactic lateral node dissection. Radioiodine ablation therapy was performed only for three patients.
Results: The 10-year disease-free survival (DFS) rate of our series was 97%. To date, recurrence was observed in 62 patients (2%) and 41 showed recurrence to the regional lymph nodes. Seventeen of 1,601 patients who received limited thyroidectomy (1%) showed recurrence to the remnant thyroid. Pathological nodal-positive patients showed a worse DFS, but the 10-year DFS rate was still high at 96%. Patients with total or near total thyroidectomy had a better DFS, but the difference disappeared if recurrence to the remnant thyroid was excluded. A number needed to treat (NNT) for total or near total thyroidectomy over hemithyroidectomy was 83 to prevent 1 recurrence.
Conclusions: These findings suggest that solitary T1N0M0 patients have an excellent prognosis when they undergo thyroidectomy and elective lymph node dissection without radioiodine therapy. Regarding the extent of thyroidectomy, hemithyroidectomy is adequate for these patients, if a 1% risk of recurrence to the remnant thyroid is accepted.
Comment in
-
Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best?World J Surg. 2010 Jun;34(6):1291-3. doi: 10.1007/s00268-010-0469-5. World J Surg. 2010. PMID: 20162281 No abstract available.
-
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.World J Surg. 2011 Jan;35(1):231-2; author reply 233-4. doi: 10.1007/s00268-010-0675-1. World J Surg. 2011. PMID: 20556610 No abstract available.
Similar articles
-
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.World J Surg. 2011 Jan;35(1):231-2; author reply 233-4. doi: 10.1007/s00268-010-0675-1. World J Surg. 2011. PMID: 20556610 No abstract available.
-
Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?World J Surg Oncol. 2014 May 20;12:152. doi: 10.1186/1477-7819-12-152. World J Surg Oncol. 2014. PMID: 24885654 Free PMC article.
-
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.Minerva Endocrinol. 2013 Sep;38(3):269-79. Minerva Endocrinol. 2013. PMID: 24126547
-
[Prospective therapy study in differentiated thyroid carcinoma].Schweiz Med Wochenschr. 1995 Nov 18;125(46):2226-36. Schweiz Med Wochenschr. 1995. PMID: 8525342 Review. German.
-
Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.World J Surg. 2007 May;31(5):905-15. doi: 10.1007/s00268-006-0722-0. World J Surg. 2007. PMID: 17219265 Review.
Cited by
-
The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis.J Clin Med. 2020 Jul 21;9(7):2316. doi: 10.3390/jcm9072316. J Clin Med. 2020. PMID: 32708218 Free PMC article. Review.
-
Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.World J Surg. 2012 Jun;36(6):1274-8. doi: 10.1007/s00268-012-1423-5. World J Surg. 2012. PMID: 22270990
-
Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy.World J Surg. 2011 Jan;35(1):231-2; author reply 233-4. doi: 10.1007/s00268-010-0675-1. World J Surg. 2011. PMID: 20556610 No abstract available.
-
Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the "con" point of view.Endocrine. 2015 Sep;50(1):67-71. doi: 10.1007/s12020-014-0523-4. Epub 2015 Jan 10. Endocrine. 2015. PMID: 25576046 Review.
-
Migration of Risk Classification Between the JAES Versus ATA guidelines for Papillary Thyroid Carcinoma.World J Surg. 2023 Jul;47(7):1729-1737. doi: 10.1007/s00268-023-06976-9. Epub 2023 Mar 15. World J Surg. 2023. PMID: 36920523
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical